Medicared For All Logo

Manjusha Kota in Hot Springs, Arkansas

Home Arkansas Hot Springs

Manjusha Kota has Hematology/oncology as her primary medical specialty. Their primary office is: 180 Medical Park Pl in Hot Springs, Arkansas. They attended Sorry, her university is not listed and graduated in 1992 (around 32 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Manjusha Kota Office Phone and Directions

Manjusha Kota
180 Medical Park Pl
Hot Springs, Arkansas 71901
501-463-5700


Patient Ratings
Please rate your experience with Manjusha Kota below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 501-463-5700


Enter a starting address:


Healthcare Info for Manjusha Kota

Medical School: Sorry, her university is not listed
Graduation Year: 1992
The Primary Medical Specialty for Manjusha Kota is listed as: Hematology/oncology
Approximate Years of Experience: 32
PAC (PECOS ID)#: 0143379750
NPI #: 1629175922
NPI Created On: 09/20/2006
NPI Last Updated Listed as: 02/13/2019
Primary Taxonomy Code: 207RH0003X
License Number:
E3542
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • QualChoice Life & Health Insurance Company, Inc.
  • USAble Mutual Insurance Company
  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: ENGL, English.


Services and Procedures include:

  1. Blood test, comprehensive group of blood chemicals
  2. Automated urinalysis test
  3. Complete blood cell count (red cells, white blood cell, platelets), automated test
  4. Blood test, clotting time
  5. Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
  6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  7. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  9. Infusion of chemotherapy into a vein up to 1 hour
  10. New patient office or other outpatient visit, typically 30 minutes
  11. New patient office or other outpatient visit, typically 45 minutes
  12. Established patient office or other outpatient visit, typically 10 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Initial hospital inpatient care, typically 50 minutes per day
  16. Initial hospital inpatient care, typically 70 minutes per day
  17. Subsequent hospital inpatient care, typically 15 minutes per day
  18. Subsequent hospital inpatient care, typically 25 minutes per day
  19. Subsequent hospital inpatient care, typically 35 minutes per day
  20. Injection, dexamethasone sodium phosphate, 1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788498445

Being Disputed:: No

Product Related: No


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788498447

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795151875

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818585223

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818598669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812757519

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: MEKINIST

Open Associated Drug #1: 0078-0666-15

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: TAFINLAR

Associated Drug #2: 0078-0681-66

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: TABRECTA

Name Of Drug #3: 0078-0709-56


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812757521

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: MEKINIST

Open Associated Drug #1: 0078-0666-15

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: TAFINLAR

Associated Drug #2: 0078-0681-66

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: TABRECTA

Name Of Drug #3: 0078-0709-56


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 841902817

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology/Endocrinology

Name of Drug #1: SOMATULINE DEPOT

Open Associated Drug #1: 15054-0060-1

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ONIVYDE

Associated Drug #2: 15054-0043-1


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 825572297

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: Nplate

Open Associated Drug #1: 55513-221-01

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: XGEVA

Associated Drug #2: 55513-730-01


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 826384991

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Kyprolis

Open Associated Drug #1: 76075-101-01


Hematology/oncology Professionals in Hot Springs

133 Harmony Park Cir
Hot-springs, AR
American Oncology Partners Pa

133 Harmony Park Cir
Hot-springs, AR
American Oncology Partners Pa

133 Harmony Park Cir
Hot-springs, AR
American Oncology Partners Pa

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry